Synthesis, Antiproliferative Effect, and Topoisomerase II Inhibitory Activity of 3-Methyl-2-phenyl-1
Journal
ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073
Informations de publication
Date de publication:
14 May 2020
14 May 2020
Historique:
received:
28
11
2019
accepted:
24
01
2020
entrez:
22
5
2020
pubmed:
22
5
2020
medline:
22
5
2020
Statut:
epublish
Résumé
A series of 3-methyl-2-phenyl-1
Identifiants
pubmed: 32435372
doi: 10.1021/acsmedchemlett.9b00557
pmc: PMC7236043
doi:
Types de publication
Journal Article
Langues
eng
Pagination
691-697Informations de copyright
Copyright © 2020 American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Mol Oncol. 2012 Apr;6(2):155-76
pubmed: 22440008
Eur J Med Chem. 2019 Jun 1;171:129-168
pubmed: 30917303
Acta Pharm Sin B. 2018 Oct;8(6):844-861
pubmed: 30505655
ACS Chem Biol. 2013 Jan 18;8(1):82-95
pubmed: 23259582
Mol Med. 2000 Jun;6(6):527-41
pubmed: 10972088
Curr Pharm Des. 2013;19(13):2474-88
pubmed: 23363399
Biochem J. 2018 Jan 23;475(2):373-398
pubmed: 29363591
Crit Rev Biochem Mol Biol. 2017 Apr;52(2):107-144
pubmed: 28094588
Annu Rev Biochem. 2001;70:369-413
pubmed: 11395412
Cancer Res. 2005 Aug 15;65(16):7470-7
pubmed: 16103101
Bioorg Med Chem. 2013 Nov 15;21(22):6965-72
pubmed: 24095013
Mutagenesis. 2006 Sep;21(5):321-5
pubmed: 16950806
Nat Rev Cancer. 2017 Aug;17(8):502-508
pubmed: 28643779
Nat Rev Mol Cell Biol. 2016 Nov;17(11):703-721
pubmed: 27649880
Leukemia. 1998 Jul;12(7):1013-25
pubmed: 9665184
J Nat Prod. 1995 Feb;58(2):217-25
pubmed: 7769390
Bioorg Med Chem Lett. 2014 Dec 15;24(24):5762-5768
pubmed: 25453816
Expert Opin Ther Pat. 2013 Aug;23(8):1033-56
pubmed: 23611704
Nat Rev Cancer. 2009 May;9(5):327-37
pubmed: 19377505
ChemMedChem. 2015 Feb;10(2):345-59
pubmed: 25522133
Exp Oncol. 2012 Oct;34(3):255-62
pubmed: 23070010
Nat Rev Cancer. 2009 May;9(5):338-50
pubmed: 19377506
BMC Chem Biol. 2009 Jan 07;9:1
pubmed: 19128485
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593